Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer

Pancreatic cancer (PC) is one of the deadliest cancers. Developing biomarkers for chemotherapeutic response prediction is crucial for improving the dismal prognosis of advanced-PC patients (pts). To evaluate the potential of plasma metabolites as predictors of the response to chemotherapy for PC pat...

Full description

Bibliographic Details
Main Authors: Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol, Neil A. Bhowmick, Jun Gong
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
pancreatic cancer
chemotherapy
FOLFIRINOX
gemcitabine/nab-paclitaxel
plasma metabolomics
Online Access:https://www.mdpi.com/2072-6694/15/11/3020

Internet

https://www.mdpi.com/2072-6694/15/11/3020

Similar Items